ConductScience.org, home

Paper37709999

MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial.

Mitchell JM and 19 others. Nat Med, 2023. Cited by 304 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial. Papers, record 37709999. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37709999

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial.
PubMed
Journal
Nat Med
PubMed
Year
2023
PubMed
Publication types
Randomized Controlled Trial, Clinical Trial, Phase III, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
304
iCite
Relative citation ratio, by iCite
45.5
iCite
Revised in PubMed
2026-05-18
PubMed

Authors20

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Mitchell JMJennifer Mhttps://orcid.org/0000-0002-7567-8129
2Ot'alora G MMarcelahttps://orcid.org/0000-0001-6174-7317
3van der Kolk BBessel
4Shannon SScott
5Bogenschutz MMichaelhttps://orcid.org/0000-0003-4530-3470
6Gelfand YYevgeniy
7Paleos CCasey
8Nicholas CRChristopher R
9Quevedo SSylvestre
10Balliett BBrooke
11Hamilton SScott
12Mithoefer MMichaelhttps://orcid.org/0000-0002-4267-6135
13Kleiman SSarah
14Parker-Guilbert KKelly
15Tzarfaty KKeren
16Harrison CCharlotte
17de Boer AAlberdina
18Doblin RRick
19Yazar-Klosinski BBerra
20MAPP2 Study Collaborator GroupGroup

Source PubMed

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Stress Disorders, Post-TraumaticMajor topic
N-Methyl-3,4-methylenedioxyamphetamineMajor topic
Humans
Treatment Outcome
Combined Modality Therapy
Double-Blind Method

Source PubMed

Trials3

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT04077437A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP2)Derived from the trialYesClinicalTrials.gov
NCT06954025High-Intensity Inpatient MDMA-Assisted Psychotherapy for PTSDResultsClinicalTrials.gov
NCT07737054Trauma-informed Psilocybin Assisted Psychotherapy (TiPAP) for PTSDBackgroundClinicalTrials.gov

Comments and corrections2

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn PapersSource
Erratum in39,375,459Author Correction: MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial.https://conductscience.org/library/papers/39375459PubMed
Comment in37,967,550Expectancy Effects Cannot Be Neglected in MDMA-Assisted Therapy Research.https://conductscience.org/library/papers/37967550PubMed

References38

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
111,119,398Cardiovascular effects of 3,4-methylenedioxymethamphetamine. A double-blind, placebo-controlled trial.Ann Intern Med2000https://conductscience.org/library/papers/11119398PubMed
232,063,234Psychological treatments for post-traumatic stress disorder in adults: a network meta-analysis.Psychol Med2020https://conductscience.org/library/papers/32063234PubMed
326,408,071The prosocial effects of 3,4-methylenedioxymethamphetamine (MDMA): Controlled studies in humans and laboratory animals.Neurosci Biobehav Rev2015https://conductscience.org/library/papers/26408071PubMed
430,685,564Comparability of blinded remote and site-based assessments of response to adjunctive esketamine or placebo nasal spray in patients with treatment resistant depression.J Psychiatr Res2019https://conductscience.org/library/papers/30685564PubMed
536,352,123Serotonin-releasing agents with reduced off-target effects.Mol Psychiatry2023https://conductscience.org/library/papers/36352123PubMed
631,572,236Breakthrough for Trauma Treatment: Safety and Efficacy of MDMA-Assisted Psychotherapy Compared to Paroxetine and Sertraline.Front Psychiatry2019https://conductscience.org/library/papers/31572236PubMed
734,227,438Who is blind in psychedelic research? Letter to the editor regarding: blinding and expectancy confounds in psychedelic randomized controlled trials.Expert Rev Clin Pharmacol2021https://conductscience.org/library/papers/34227438PubMed
835,910,354Effects of 3,4-Methylenedioxymethamphetamine on Conditioned Fear Extinction and Retention in a Crossover Study in Healthy Subjects.Front Pharmacol2022https://conductscience.org/library/papers/35910354PubMed
928,493,729The Clinician-Administered PTSD Scale for DSM-5 (CAPS-5): Development and initial psychometric evaluation in military veterans.Psychol Assess2018https://conductscience.org/library/papers/28493729PubMed
1035,401,275Entactogens: How the Name for a Novel Class of Psychoactive Agents Originated.Front Psychiatry2022https://conductscience.org/library/papers/35401275PubMed
1129,975,339Conceptualization, Assessment, and Treatment of Traumatic Stress in First Responders: A Review of Critical Issues.Harv Rev Psychiatry2018https://conductscience.org/library/papers/29975339PubMed
1231,607,239Dissociative subtype of posttraumatic stress disorder in women in partial and residential levels of psychiatric care.J Trauma Dissociation2020https://conductscience.org/library/papers/31607239PubMed
1331,065,731MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials.Psychopharmacology (Berl)2019https://conductscience.org/library/papers/31065731PubMed
1435,727,042
MDMA-assisted therapy for posttraumatic stress disorder: A pooled analysis of ethnoracial differences in efficacy and safety from two Phase 2 open-label lead-in trials and a Phase 3 randomized, blinded placebo-controlled trial.
J Psychopharmacol2022https://conductscience.org/library/papers/35727042PubMed
1524,097,374MDMA enhances emotional empathy and prosocial behavior.Soc Cogn Affect Neurosci2014https://conductscience.org/library/papers/24097374PubMed
1624,403,876MDMA (3,4-Methylenedioxymethamphetamine) Analogues as Tools to Characterize MDMA-Like Effects: An Approach to Understand Entactogen Pharmacology.Curr Neuropharmacol2013https://conductscience.org/library/papers/24403876PubMed
1734,586,365Demographic and Health Behavior Factors Associated With Clinical Trial Invitation and Participation in the United States.JAMA Netw Open2021https://conductscience.org/library/papers/34586365PubMed
1831,780,134Comorbidity in post-traumatic stress disorder: A population-based study from the two largest cities in Brazil.J Affect Disord2020https://conductscience.org/library/papers/31780134PubMed
1929,524,515MDMA-assisted psychotherapy for PTSD: Are memory reconsolidation and fear extinction underlying mechanisms?Prog Neuropsychopharmacol Biol Psychiatry2018https://conductscience.org/library/papers/29524515PubMed
2022,346,334Pharmacotherapy for Post-traumatic Stress Disorder In Combat Veterans: Focus on Antidepressants and Atypical Antipsychotic Agents.P T2012https://conductscience.org/library/papers/22346334PubMed

See all 38 references

Cited by213

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 304 citations.

PMIDTitleJournalYearIn PapersSource
42,974,518Psychedelics in neurosurgery: Potential utility in prevention, perioperative care, pain management, and neurorehabilitation.Surg Neurol Int2026https://conductscience.org/library/papers/42974518PubMed
42,972,049A multi-institutional investigation of psilocybin's effects on mouse behavior.Nat Neurosci2026https://conductscience.org/library/papers/42972049PubMed
42,957,826Evolutionary neuropharmacology of serotonergic psychedelics: a cross-species perspective on mechanisms, consciousness, and therapeutic potential.Mol Psychiatry2026https://conductscience.org/library/papers/42957826PubMed
42,898,320Caution before canonisation: a clinical and implementation science perspective on psychedelics.Front Psychiatry2026https://conductscience.org/library/papers/42898320PubMed
42,891,831What goes up must comedown: prevalence rates, characteristics, and coping strategies concerning MDMA aftereffects.Psychopharmacology (Berl)2026https://conductscience.org/library/papers/42891831PubMed
42,875,076La psychothérapie assistée par des agents psychédéliques: Un paradigme émergent.Can Fam Physician2026https://conductscience.org/library/papers/42875076PubMed
42,875,067Psychedelic-assisted psychotherapy: Emerging paradigm.Can Fam Physician2026https://conductscience.org/library/papers/42875067PubMed
42,864,445Investigating molecular and hemodynamic effects of LSD in the human brain.Nat Neurosci2026https://conductscience.org/library/papers/42864445PubMed
42,860,436A living systematic review, meta-analysis, and open data resource of trials of MDMA-assisted therapy for PTSD.Neuropsychopharmacology2026https://conductscience.org/library/papers/42860436PubMed
42,823,699Post-traumatic stress disorder: outline and updated insights focusing on occupational factors.J Occup Med Toxicol2026https://conductscience.org/library/papers/42823699PubMed
42,812,288Lived experience as systems-relevant evidence in psychedelic public health.Front Public Health2026https://conductscience.org/library/papers/42812288PubMed
42,809,289Adverse Health Outcomes of Psilocybin, LSD, MDMA, Ibogaine, and 5-MeO-DMT.JAMA Netw Open2026https://conductscience.org/library/papers/42809289PubMed
42,809,102Moving beyond 5-HT2A: language models map neurotransmitter receptors to experiential semantics.Psychopharmacology (Berl)2026https://conductscience.org/library/papers/42809102PubMed
42,772,319Psychedelic-assisted therapy research for people with HIV.Lancet HIV2026https://conductscience.org/library/papers/42772319PubMed
42,761,569A national approach in a European context: Multidisciplinary and multiprofessional recommendations on the clinical use of psychedelic substances.Neurosci Appl2026https://conductscience.org/library/papers/42761569PubMed
42,735,067The Nova Protocol: a comprehensive multimodal longitudinal study among civilian survivors of a mass trauma event.Eur J Psychotraumatol2026https://conductscience.org/library/papers/42735067PubMed
42,687,955Medical and Psychiatric Consultation for Patients Considering State-Regulated Psilocybin Services: A Risk-Reduction Model and Two Illustrative Cases.Res Sq2026https://conductscience.org/library/papers/42687955PubMed
42,653,026Psychedelic Safety and Clinical Outcomes Across Exposure Patterns: A Structured Narrative Review.Life (Basel)2026https://conductscience.org/library/papers/42653026PubMed
42,577,141Medicine 4.0: the era of revolutionary access.Front Med (Lausanne)2026https://conductscience.org/library/papers/42577141PubMed
42,563,280Permissive and instructive causality: integrating biological and environmental factors in mental health.Psychol Med2026https://conductscience.org/library/papers/42563280PubMed

See all 213 cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
AP2B1163PubTator's text mininghttps://conductscience.org/library/genes/163

Source NCBI Gene

Drugs1

The drugs whose trials, in the Pipelines release, list the paper.

DrugChEMBL IDThe trials list it asTrialsIn Drugs and targets
MIDOMAFETAMINECHEMBL43048Results2https://conductscience.org/library/drugs/CHEMBL43048

Source ChEMBL

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37709999

GET https://conductscience.org/api/papers/v1/37709999/references?page=2